Novo Nordisk Confirms Cyberattack Exposing Clinical Trial Data and AI Assets

On 11 June 2026, Novo Nordisk A/S—best known for its weight‑loss drugs Ozempic and Wegovy—publicly confirmed a cyb...

Read story →